These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 26429974

  • 1. Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.
    Bhandari S, Ives N, Brettell EA, Valente M, Cockwell P, Topham PS, Cleland JG, Khwaja A, El Nahas M.
    Nephrol Dial Transplant; 2016 Feb; 31(2):255-61. PubMed ID: 26429974
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD007751. PubMed ID: 21975774
    [Abstract] [Full Text] [Related]

  • 3. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R, Rios P, Baldovinos G, Chichet MA, Perg N, Sola L, Saona G, De Souza N, Lamadrid V, Gadola L.
    Nephron; 2019 Oct 05; 143(2):100-107. PubMed ID: 31203280
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease.
    Bhandari S, Mehta S, Khawaja A, Cleland JGF, Ives N, Cockwell P.
    Kidney Int; 2024 Jan 05; 105(1):200-208. PubMed ID: 37783444
    [Abstract] [Full Text] [Related]

  • 5. Aldosterone antagonists for preventing the progression of chronic kidney disease.
    Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF.
    Cochrane Database Syst Rev; 2014 Apr 29; (4):CD007004. PubMed ID: 24782282
    [Abstract] [Full Text] [Related]

  • 6. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
    Huang RS, Cheng YM, Zeng XX, Kim S, Fu P.
    Chin Med J (Engl); 2016 Mar 05; 129(5):562-9. PubMed ID: 26904991
    [Abstract] [Full Text] [Related]

  • 7.
    Bhandari S, Mehta S, Khwaja A, Cleland J, Ives N, Brettell E, Chadburn M, Cockwell P, for the STOP-ACEi Trial Investigators.
    ; 2024 03 05. PubMed ID: 38564538
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
    Ahmed A, Jorna T, Bhandari S.
    Nephron; 2016 03 05; 133(3):147-58. PubMed ID: 27336470
    [Abstract] [Full Text] [Related]

  • 10. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
    de Goeij MC, Liem M, de Jager DJ, Voormolen N, Sijpkens YW, Rotmans JI, Boeschoten EW, Dekker FW, Grootendorst DC, Halbesma N, PREPARE-1 Study Group.
    Nephron Clin Pract; 2012 03 05; 121(1-2):c73-82. PubMed ID: 23128440
    [Abstract] [Full Text] [Related]

  • 11. Association of ACEI/ARB therapy with total and cardiovascular death in coronary artery disease patients with advanced chronic kidney disease: a large multi-center longitudinal study.
    Lai W, Zhao X, Zhang T, Huang D, Liang G, Zhou Y, Liu J, Chen S, Liu Y.
    Ren Fail; 2024 Dec 05; 46(2):2398189. PubMed ID: 39229915
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population.
    Zheng CM, Wang JY, Chen TT, Wu YC, Wu YL, Lin HT, Chiu SP, Chang TJ, Zheng JQ, Chu NF, Lin YM, Su SL, Lu KC, Chen JS, Sung FC, Lee CT, Yang Y, Hwang SJ, Wang MC, Hsu YH, Chiou HY, Kao S, Wu MY, Lin YF.
    Sci Rep; 2019 Feb 25; 9(1):2694. PubMed ID: 30804406
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease : A Systematic Review and Retrospective Individual Participant-Level Meta-analysis of Clinical Trials.
    Ku E, Inker LA, Tighiouart H, McCulloch CE, Adingwupu OM, Greene T, Estacio RO, Woodward M, de Zeeuw D, Lewis JB, Hannedouche T, Jafar TH, Imai E, Remuzzi G, Heerspink HJL, Hou FF, Toto RD, Li PK, Sarnak MJ.
    Ann Intern Med; 2024 Jul 25; 177(7):953-963. PubMed ID: 38950402
    [Abstract] [Full Text] [Related]

  • 14. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR, Rahim S, Etherington K, Rokoss ML, Natarajan MK, Velianou JL, Brons S, Mehta SR, CAPTAIN Investigators.
    Am Heart J; 2015 Jul 25; 170(1):110-6. PubMed ID: 26093871
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
    Evans M, Carrero JJ, Szummer K, Åkerblom A, Edfors R, Spaak J, Jacobson SH, Andell P, Lindhagen L, Jernberg T.
    J Am Coll Cardiol; 2016 Apr 12; 67(14):1687-97. PubMed ID: 27056774
    [Abstract] [Full Text] [Related]

  • 16. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ.
    Am J Kidney Dis; 2021 May 12; 77(5):719-729.e1. PubMed ID: 33246024
    [Abstract] [Full Text] [Related]

  • 17. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS, Chang SH, Chang GJ, Liu JR, Chan YH, Lee HF, Wen MS, Chen WJ, Yeh YH, Kuo CT, See LC.
    Cardiovasc Diabetol; 2016 Apr 02; 15():56. PubMed ID: 27039185
    [Abstract] [Full Text] [Related]

  • 18. Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?
    Brooks JM, Chapman CG, Suneja M, Schroeder MC, Fravel MA, Schneider KM, Wilwert J, Li YJ, Chrischilles EA, Brenton DW, Brenton M, Robinson J.
    J Am Heart Assoc; 2018 May 30; 7(11):. PubMed ID: 29848495
    [Abstract] [Full Text] [Related]

  • 19. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Fröhlich H, Nelges C, Täger T, Schwenger V, Cebola R, Schnorbach J, Goode KM, Kazmi S, Katus HA, Cleland JG, Clark AL, Frankenstein L.
    Am Heart J; 2016 Aug 30; 178():28-36. PubMed ID: 27502849
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of dual vs single renin-angiotensin-aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials.
    Zhao M, Qu H, Wang R, Yu Y, Chang M, Ma S, Zhang H, Wang Y, Zhang Y.
    Medicine (Baltimore); 2021 Sep 03; 100(35):e26544. PubMed ID: 34477114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.